- £78.47m
- £77.13m
- £1.69m
Annual balance sheet for 4Basebio, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 9.59 | 4.35 | 3.07 | 34.6 | 17.8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.604 | 1.02 | 1.18 | 1.35 | 0.289 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 10.6 | 5.9 | 5.02 | 36.9 | 20.7 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.76 | 3.63 | 4.2 | 4.33 | 4.03 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 14.7 | 11.7 | 11.9 | 44.7 | 29.5 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.52 | 1.52 | 2.28 | 3.27 | 2.83 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.01 | 4.57 | 12.4 | 18.3 | 19.4 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 11.7 | 7.12 | -0.492 | 26.4 | 10.1 |
| Total Liabilities & Shareholders' Equity | 14.7 | 11.7 | 11.9 | 44.7 | 29.5 |
| Total Common Shares Outstanding |